stoxline Quote Chart Rank Option Currency Glossary
  
Amphastar Pharmaceuticals, Inc. (AMPH)
55.95  0.86 (1.56%)    02-27 15:17
Open: 55.85
High: 56.36
Volume: 304,964
  
Pre. Close: 55.09
Low: 55.058
Market Cap: 2,680(M)
Technical analysis
2024-02-27 2:42:59 PM
Short term     
Mid term     
Targets 6-month :  66.3 1-year :  77.44
Resists First :  56.77 Second :  66.3
Pivot price 54.06
Supports First :  53.25 Second :  51.08
MAs MA(5) :  53.51 MA(20) :  53.89
MA(100) :  53.77 MA(250) :  49.99
MACD MACD :  -0.5 Signal :  -0.7
%K %D K(14,3) :  69.3 D(3) :  44.8
RSI RSI(14): 55
52-week High :  67.66 Low :  33.61
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ AMPH ] has closed below upper band by 19.1%. Bollinger Bands are 20.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 55.77 - 55.99 55.99 - 56.23
Low: 52.85 - 53.08 53.08 - 53.31
Close: 54.71 - 55.11 55.11 - 55.53
Company Description

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Headline News

Tue, 27 Feb 2024
Eagle Asset Management Inc. Has $1.73 Million Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Tue, 27 Feb 2024
Amphastar Pharmaceuticals (AMPH) to Release Quarterly Earnings on Wednesday - MarketBeat

Mon, 26 Feb 2024
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Charles Schwab Investment Management Inc. - AmericanBankingNEWS

Sun, 25 Feb 2024
Monashee Investment Management LLC Takes Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Sat, 24 Feb 2024
DekaBank Deutsche Girozentrale Purchases 4048 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - AmericanBankingNEWS

Thu, 22 Feb 2024
Amphastar Pharmaceuticals (AMPH) Increases Yet Falls Behind Market: What Investors Need to Know - Zacks Investment Research

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Drug Manufacturers—Specialty & Generic
Shares Out 48 (M)
Shares Float 38 (M)
Held by Insiders 21.4 (%)
Held by Institutions 71.1 (%)
Shares Short 3,190 (K)
Shares Short P.Month 2,780 (K)
Stock Financials
EPS 2.55
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 12.43
Profit Margin 22.5 %
Operating Margin 40.2 %
Return on Assets (ttm) 10.1 %
Return on Equity (ttm) 24.5 %
Qtrly Rev. Growth 50.2 %
Gross Profit (p.s.) 0
Sales Per Share 12.55
EBITDA (p.s.) 4.5
Qtrly Earnings Growth 203.3 %
Operating Cash Flow 175 (M)
Levered Free Cash Flow 244 (M)
Stock Valuations
PE Ratio 21.83
PEG Ratio 0.6
Price to Book value 4.49
Price to Sales 4.45
Price to Cash Flow 15.31
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android